{"id":63955,"date":"2025-01-24T12:01:27","date_gmt":"2025-01-24T12:01:27","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/01\/24\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/"},"modified":"2025-01-24T12:01:27","modified_gmt":"2025-01-24T12:01:27","slug":"tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/","title":{"rendered":"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference"},"content":{"rendered":"<div>\n<p>WARREN, N.J., Jan.  23, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZuNgcYfS6Vg6ovJNaHcj_Zs842b7d-pN1VCwxTPk_IGkK8Shci9PsBs91FxFCM-tpQORAwmFo5i2ny2pDyHJFY0cm0LmvPQPnKY2Ii6sHx4=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>Tevogen Bio Holdings Inc.<\/u><\/a> (\u201cCompany\u201d or \u201cTevogen Bio\u201d) (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hHW-pANKHPyiRYcYBeg6Iz7KlSKCwyfa4fkepN6pykSchbP3yA1gUJ8Llmso7E5Jt4MLRHh6YBilO7yvyF4Di-5MYm8q1VgNd3AN0Qjo3Es=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>TVGN<\/u><\/a>), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for infectious diseases and cancers, today announced key insights from its recent fireside chat during the J.P. Morgan Healthcare Conference. Utilizing artificial intelligence (AI) and machine learning (ML) has been critical for Tevogen Bio, given its core commitment to patient equity. By applying ML through Tevogen.AI, the company has already achieved notable cost and time efficiencies, developments that could translate directly into savings for patients. The discussion featured Dr. David Rhew, Global Chief Medical Officer &amp; VP of Healthcare at Microsoft (Nasdaq: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YuNUvrta1NH_1932N53qzs2cOsGTEqykKrGnWEVeWfYPSZI4I7NxM9WOLJOVnQJkgG78lBOQsVLXe019OgcQMoXgbHSLddUHUxxUNg8FImY=\" rel=\"nofollow\" target=\"_blank\" title=\"MSFT\">MSFT<\/a>), and Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, who shared their vision for how AI is revolutionizing drug development and healthcare delivery.<\/p>\n<p><strong>Accelerating Drug Discovery<\/strong><\/p>\n<p>In the fireside chat, Dr. Rhew described how AI-driven modeling and simulation are drastically reducing the time required to identify and develop drug candidates. He provided an example where a computational task that previously may have taken \u201cthousands of years\u201d using traditional approaches was completed in a matter of months thanks to AI-powered tools. These breakthroughs, Dr. Rhew noted, illustrate a paradigm shift in what is now possible in the pharmaceutical research and development process.<\/p>\n<p><strong>The Rise of Generative AI and Multimodal Data<\/strong><\/p>\n<p>Both speakers emphasized that while generative AI has garnered widespread attention, next-generation approaches extend beyond simply creating text or images. According to Dr. Rhew, organizations are increasingly deploying multimodal data AI, which processes data from diverse sources, such as imaging, genomics, and electronic health records, to reveal novel insights. Generative AI then serves as a powerful query engine on top of these \u201cfoundation models,\u201d enabling seamless interpretation and conversion of complex data into clinically relevant results and formats.<\/p>\n<p><strong>Ensuring Data Quality, Privacy, and Responsible AI<\/strong><\/p>\n<p>Speaking to Tevogen Bio\u2019s AI developments, Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, highlighted, \u201cWe are creating curated datasets, supported by wet-lab research, to fuel the creation of reliable foundational AI models.&#8221; Dr. Rhew echoed the need for \u201cclean\u201d and \u201cannotated\u201d datasets, stating, \u201cAI is like a powerful engine. It can take us anywhere, but it needs clean, curated data as fuel. Crude data won&#8217;t work; it must be refined and properly annotated to be useful.&#8221; Both speakers also stressed the importance of strong data governance and privacy-preserving techniques, such as federated learning and confidential compute, which enable secure collaboration on sensitive datasets without exposing proprietary information or intellectual property. Dr. Rhew underscored that responsible AI requires bias mitigation, transparency, and continuous oversight. Mr. Mehta commended Microsoft\u2019s commitment to these principles, stating that responsible development practices are vital to ensuring equitable and safe adoption of AI technologies in healthcare.<\/p>\n<p>\u201cAI is the next industrial revolution and could be humanity\u2019s greatest leap yet.\u00a0I commend efforts similar to Stargate for their investment in forward-thinking and transformative technologies,\u201d said Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio. \u201cDrug development will undoubtedly improve with the power of AI, but the key is to seamlessly bridge medical science and technology. As a biotech focused on pioneering through AI, we remain committed to advancing affordable medical innovation.\u201d<\/p>\n<p><strong>About Tevogen Bio<\/strong><\/p>\n<p>Tevogen Bio is a clinical-stage specialty immunotherapy company harnessing one of nature\u2019s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Bio Leadership believes that sustainability and commercial success in the current era of healthcare rely on ensuring patient accessibility through advanced science and innovative business models. Tevogen Bio has reported positive safety data from its proof-of-concept clinical trial, and its key intellectual property assets are wholly owned by the company, not subject to any third-party licensing agreements. These assets include three granted patents, nine pending US and twelve ex-US pending patents, two of which are related to artificial intelligence.<\/p>\n<p>Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio\u2019s leadership believes that accessible personalized therapeutics are the next frontier of medicine, and that disruptive business models are required to sustain medical innovation.<\/p>\n<p><strong>Contacts<\/strong><\/p>\n<p>Tevogen Bio Communications<br \/>T: 1 877 TEVOGEN, Ext 701 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XFTobEQhXu21gODQqlbabkBsmgcTiHDKcIXFZlgSFDLcVini5N5mTKUV6w0AHbtzywD0bK_1Spv-tu0ZhDKk2WwoygUKJFm_MRbGK5nV6wMpRjsKmISDFD_zuXibLkgi\" rel=\"nofollow\" target=\"_blank\" title=\"Communications@Tevogen.com\">Communications@Tevogen.com<\/a><\/p>\n<p align=\"center\"><img loading=\"lazy\" decoding=\"async\" alt=\"Mittul Mehta, Chief Information Officer and Head of Tevogen.AI, and Dr. David Rhew, Global Chief Medical Officer &amp; VP of Healthcare at Microsoft\" height=\"600\" name=\"GNW_RichHtml_External_IMG\" src=\"https:\/\/ml.globenewswire.com\/Resource\/Download\/8f6d82a7-ae1f-40ac-888f-dbd580e3af4b\/press-release-photo.png\" width=\"429\"><\/p>\n<p>A photo accompanying this announcement is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aGpwDL1pa2OY-R9LnNyO-cu1H4wz_Fm5Mf64UuCTAOmtrALNXvy_6tdMjAc_CqWybwOkEKQJagksHKf2jaKB5t7doYXHXuiHvtaiUDZHvHzCjunt0-nwcTp3ugSrvQlyJqDz9oE-nKXG2ffJSdialkG7q7jci5-vvT1SLT1usLXCYLfYWd_mWMtcJrdo_XHqLxY5DJcmOi3GdB1AGog4WxR8rGoGlgrE4n5Z12UvBBOkInk0H4XWmfuwSDGM_VereOqGNQErcv9wrFl0VQlreg==\" rel=\"nofollow\" target=\"_blank\" title=\"\">https:\/\/www.globenewswire.com\/NewsRoom\/AttachmentNg\/8f6d82a7-ae1f-40ac-888f-dbd580e3af4b<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDY4NDhjYjAtYmU4Yi00ZTkwLWJjZDMtZGRmZGMzYTIxYWY0LTEzMDE0Njc=\/tiny\/Tevogen-Bio-Inc.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) &#8212; Tevogen Bio Holdings Inc. (\u201cCompany\u201d or \u201cTevogen Bio\u201d) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for infectious diseases and cancers, today announced key insights from its recent fireside chat during the J.P. Morgan Healthcare Conference. Utilizing artificial intelligence (AI) and machine [&#8230;]\n","protected":false},"author":1,"featured_media":63956,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-63955","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference\" \/>\n<meta property=\"og:description\" content=\"WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) &#8212; Tevogen Bio Holdings Inc. (\u201cCompany\u201d or \u201cTevogen Bio\u201d) (Nasdaq: TVGN), a clinical-stage s\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-24T12:01:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/press-release-photo-732x1024.png\" \/>\n\t<meta property=\"og:image:width\" content=\"732\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference\",\"datePublished\":\"2025-01-24T12:01:27+00:00\",\"dateModified\":\"2025-01-24T12:01:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/\"},\"wordCount\":777,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/\",\"name\":\"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-01-24T12:01:27+00:00\",\"dateModified\":\"2025-01-24T12:01:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference","og_description":"WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) &#8212; Tevogen Bio Holdings Inc. (\u201cCompany\u201d or \u201cTevogen Bio\u201d) (Nasdaq: TVGN), a clinical-stage s","og_url":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-01-24T12:01:27+00:00","og_image":[{"width":732,"height":1024,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/01\/press-release-photo-732x1024.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference","datePublished":"2025-01-24T12:01:27+00:00","dateModified":"2025-01-24T12:01:27+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/"},"wordCount":777,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/","url":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/","name":"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-01-24T12:01:27+00:00","dateModified":"2025-01-24T12:01:27+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/tevogen-bio-highlights-the-future-of-ai-driven-drug-development-in-fireside-chat-with-microsoft-during-the-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/63955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=63955"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/63955\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/63956"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=63955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=63955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=63955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}